1. Analytical comparability study of recombinant monoclonal antibody therapeutics;Ambrogelly;MAbs,2018
2. Characterizing biological products and assessing comparability following manufacturing changes;Chirino;Nat Biotechnol,2004
3. ICH Expert Working Group. Comparability of biotechnological/biological products subject to changes in their manufacturing process Q5E. ICH Harmonized Tripartite Guideline; 2004.
4. Committee for medicinal products for human use (CHMP), European Medicines Agency. Guideline on comparability of biotechnology-derived medicinal products after a change in the manufacturing process: non-clinical and clinical issues. 19 July 2007. EMEA/CHMP/BMWP/101695/2006.
5. Risk-based comparability assessment for monoclonal antibodies during drug development: a clinical pharmacology perspective;Zhuang;AAPS J,2018